KR vs PMCB · P/E 19, rev $147.12B vs $8.6M cap
Kroger Company (KR) versus PharmaCyte Biotech Inc (PMCB) — a side-by-side from cached financials, not a winner call.
Kroger Company (KR) is a grocery stores company listed on US.
PharmaCyte Biotech Inc (PMCB) is a biotechnology company listed on NASDAQ.
Latest reported KR revenue for 2025-02-01 was $147.12B. Net income was $2.67B. KR currently screens at market cap $46.17B and trailing P/E 19.0.
Latest reported PMCB revenue for 2025-04-30 was $0. Net income was $30.7M. PMCB currently screens at market cap $8.6M.
KR currently screens at market cap $46.17B and trailing P/E 19.0. PMCB currently screens at market cap $8.6M.
Not investment advice. Open the KR and PMCB stock pages for the full models.
Not investment advice.